Differential Elimination of Anti-Thymocyte Globulin of Fresenius and Genzyme Impacts T-Cell Reconstitution After Hematopoietic Stem Cell Transplantation

Anti-thymocyte globulin (ATG) is a lymphocyte depleting agent applied in hematopoietic stem cell transplantation (HSCT) to prevent rejection and Graft-vs.-Host Disease (GvHD). In this study, we compared two rabbit ATG products, ATG-Genzyme (ATG-GENZ), and ATG-Fresenius (ATG-FRES), with respect to do...

Descripción completa

Detalles Bibliográficos
Autores principales: Oostenbrink, Lisa V. E., Jol-van der Zijde, Cornelia M., Kielsen, Katrine, Jansen-Hoogendijk, Anja M., Ifversen, Marianne, Müller, Klaus G., Lankester, Arjan C., van Halteren, Astrid G. S., Bredius, Robbert G. M., Schilham, Marco W., van Tol, Maarten J. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414431/
https://www.ncbi.nlm.nih.gov/pubmed/30894854
http://dx.doi.org/10.3389/fimmu.2019.00315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414431/
https://www.ncbi.nlm.nih.gov/pubmed/30894854
http://dx.doi.org/10.3389/fimmu.2019.00315

Ejemplares similares